Markets › LSE › CLBX.L

CelLBxHealth plc

LSE:CLBX.LHealthcareFTSE:AXX

£0.0078−3.13%At closeAt close · Tue 20 Oct · ≈ AED 0.0379 · Market cap $12.1M · Next earnings Thu 29 Apr

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	−100.7%	−74.5%	−133.9%	−513.2%	−313.8%	−600.7%	−286.9 pts
Operating margin	−1,726.6%	−1,714.5%	−2,427.0%	−913.9%	−538.1%	−1,089.6%	−551.6 pts
Net margin	−1,523.1%	−1,481.9%	−2,083.2%	−921.0%	−497.0%	−1,444.0%	−947.0 pts
EBITDA margin	−1,547.6%	−1,569.8%	−2,234.2%	−830.3%	−481.3%	−958.0%	−476.6 pts
Return on equity	−33.8%	−37.2%	−54.1%	−87.8%	−77.1%	−271.1%	−194.0 pts
Return on assets	−29.7%	−31.7%	−43.5%	−64.6%	−55.9%	−155.0%	−99.2 pts
Return on capital employed	−37.3%	−41.0%	−56.6%	−73.3%	−69.4%	−167.0%	−97.7 pts
Debt / equity	0.0×	0.1×	0.1×	0.2×	0.2×	0.3×	+10.6%
Debt / assets	3.5%	4.9%	10.0%	14.6%	16.5%	14.4%	−2.1 pts
Interest coverage	−143.0×	−110.6×	−68.7×	−61.5×	−50.2×	−56.2×	−12.0%
Current ratio	8.7×	8.0×	7.4×	5.4×	5.0×	2.8×	−45.3%
Quick ratio	8.5×	7.7×	7.0×	5.0×	4.6×	2.4×	−47.0%
Cash ratio	3.2×	6.5×	6.1×	4.1×	3.2×	1.9×	−39.1%
Asset turnover	0.0×	0.0×	0.0×	0.1×	0.1×	0.1×	−4.5%
Inventory turnover	2.1×	1.0×	1.2×	8.0×	7.5×	7.3×	−2.6%
Receivables turnover	0.2×	0.2×	0.2×	0.7×	0.6×	1.0×	+54.7%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—